Profile data is unavailable for this security.
About the company
Sygnis SA is a Poland-based company, which egages in Research and Development (R&D) activities. The Company is active in four segments: Bioconvergence, Nanotechnology, Power Engineering, and New Incremental Technologies. Bioconvergence is a segment in which research is conducted to prevent the shortage of organs for transplants by bioprinting organs and creating bionic models for drug testing. The Nanotechnology segment is focused on using solutions from the field of photoelectron spectroscopy, and critical atomic force microscopy in casual products. The Power Engineering segment is focused on new methods of energy storage for renewable energy and other sources. New Incremental Technologies is focused on the development of solutions regarding 3D printing. The Company cooperates with over 85 specialists such as physicists, mechatronics, chemists, engineers, designers, and sociologists, and is involved in multiple projects.
- Revenue in PLN (TTM)15.75m
- Net income in PLN-8.22m
- Incorporated2011
- Employees--
- LocationSygnis SAul. Zwirki i Wigury 101WARSZAWA 02-089PolandPOL
- Phone+48 226684757
- Fax+48 587396441
- Websitehttps://sygnis.pl/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Rented Sector SA | 200.00k | 27.20k | 6.34m | -- | 233.12 | -- | 67.64 | 31.71 | 0.0206 | 0.0206 | 0.1514 | -0.035 | 1.79 | -- | 2.20 | -- | 24.28 | 1,266.23 | -- | -- | 23.89 | -1,935.55 | 13.60 | 2,755.44 | -- | -- | -- | -- | -- | -- | -66.26 | -- | -- | -- |
| Inno-Gene SA | 1.13m | -1.46m | 9.69m | 27.00 | -- | 1.47 | -- | 8.59 | -0.2559 | -0.2559 | 0.1979 | 1.16 | 0.1086 | 4.67 | 0.673 | -- | -14.04 | 7.92 | -19.07 | 10.73 | 39.18 | 73.63 | -129.34 | 11.59 | 2.58 | -- | 0.0362 | -- | -93.08 | -16.73 | -542.12 | -- | -- | -- |
| Braster SA | 319.00k | -4.75m | 16.24m | 10.00 | -- | -- | -- | 50.91 | -0.1647 | -0.1647 | 0.011 | -0.1507 | 0.016 | 0.0039 | 8.08 | 31,900.00 | -23.81 | -29.93 | -252.42 | -72.54 | 94.36 | 79.59 | -1,488.40 | -1,124.89 | 0.306 | -2.92 | 1.64 | -- | -88.96 | -18.11 | 28.68 | -- | -- | -- |
| Sygnis SA | 15.75m | -8.22m | 17.37m | -- | -- | -- | -- | 1.10 | -0.3614 | -0.3614 | 0.6925 | -- | -- | -- | -- | -- | -- | -6.10 | -- | -9.57 | 50.82 | 56.46 | -53.74 | -22.44 | -- | -10.62 | -- | -- | -33.38 | 44.26 | -266.18 | -- | -- | -- |
| Genxone SA | 2.39m | -3.72m | 20.11m | -- | -- | 1.34 | -- | 8.40 | -1.13 | -1.13 | 0.7265 | 4.54 | 0.1358 | 13.39 | 5.04 | -- | -21.09 | 14.58 | -22.04 | 16.46 | -23.18 | 48.42 | -155.31 | 20.41 | 16.91 | -- | 0.0039 | -- | -77.38 | 111.39 | -874.87 | -- | -28.78 | -- |
| Nanogroup SA | 2.02k | -7.89m | 20.60m | -- | -- | 4.60 | -- | 10,197.97 | -0.3926 | -0.3926 | 0.0001 | 0.2228 | 0.0002 | 17.60 | 0.0349 | -- | -56.82 | -23.18 | -67.19 | -26.06 | -47,764.85 | -278.03 | -391,395.10 | -1,567.57 | 0.5186 | -2,409.12 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
| Stem Cells Spin SA | 419.33k | -154.34k | 20.67m | 1.00 | -- | 2.78 | 22.20 | 49.29 | -0.0037 | -0.0037 | 0.0101 | 0.1797 | 0.0295 | 0.0746 | 1.57 | 419,330.00 | -1.09 | -1.14 | -1.78 | -1.93 | 89.36 | 94.37 | -36.81 | -45.36 | 0.0364 | -33.81 | 0.0153 | -- | 68.84 | -4.37 | -680.05 | -- | -52.67 | -- |
| Pure Biologics SA | 109.00k | -31.72m | 24.11m | 53.00 | -- | 1.85 | -- | 221.15 | -11.15 | -11.15 | 0.0377 | 4.05 | 0.0023 | -- | 0.1026 | 1,135.42 | -66.46 | -48.68 | -81.74 | -83.38 | -3,960.55 | 38.81 | -29,097.25 | -195.73 | -- | -11.41 | 0.7606 | -- | 160.63 | -7.58 | -117.62 | -- | -- | -- |
| Cannabis Poland SA | 199.93k | -675.76k | 35.87m | -- | -- | 65.85 | -- | 179.41 | -0.0255 | -0.0255 | 0.0076 | 0.0111 | 0.3018 | 0.8264 | 5.07 | -- | -102.76 | -116.92 | -175.94 | -136.30 | 26.16 | 12.29 | -340.53 | -959.39 | 1.35 | -45.88 | 0.2547 | -- | -47.55 | 50.23 | 14.30 | -- | -- | -- |
| GENOMED SA | 22.48m | 996.34k | 37.00m | -- | 37.13 | 3.65 | 22.91 | 1.65 | 0.7541 | 0.7541 | 17.01 | 7.66 | 2.00 | 6.29 | 13.81 | -- | 8.87 | 7.90 | 10.24 | 9.33 | 42.85 | 38.56 | 4.43 | 3.93 | 4.10 | 3,257.61 | -- | -- | 9.85 | 3.87 | 193.38 | -7.69 | -32.19 | -- |
| Inventionmed SA | 610.00 | -2.46m | 43.40m | 9.00 | -- | 8.10 | -- | 71,141.73 | -0.0121 | -0.0121 | 0.00 | 0.0264 | 0.00002 | -- | 0.0004 | 67.78 | -7.00 | -18.09 | -11.73 | -23.28 | -1,288.53 | -48.77 | -403,196.70 | -43,186.79 | -- | -2.11 | -- | -- | -85.01 | -- | 88.90 | -- | -- | -- |
